Cite
MLA Citation
B Creyns et al.. “DOP018 Baseline ILC1 distribution in blood predicts response to ustekinumab in patients with refractory Crohn's disease.” Journal of Crohn's and colitis, vol. 12, n.d., pp. S041–S042. http://access.bl.uk/ark:/81055/vdc_100095484538.0x000012